U-87MG（人恶性脑胶质瘤）
CBP60299
询 价
索取STR
产品描述
产品数据库
| I. General information | |
| Synonyms: | U-87MG |
| Background: | This is one of a number of cell lines derived from malignant gliomas (see also ATCC® HTB-15™ and HTB-16™) by J. Ponten and associates from 1966 to 1969 (see also Allen, 2016). |
| Species: | Homo sapiens, human |
| Tissue: | brain |
| Disease: | Likely glioblastoma |
| Gender: | male |
| Morphology: | epithelial |
| Growth Mode: | adherent |
| DNA Profile: | Amelogenin: X,Y CSF1PO: 10,11 D13S317: 8,11 D7S820: 8,9 D5S818: 11,12 D16S539: 12 vWA: 15,17 THO1: 9.3 TPOX: 8 Our Cell Line Authentication Service |
| Culture Medium: |
MEM + 1% Non Essential Amino Acids (NEAA) + 1mM Sodium Pyruvate (NaP) + 10% FBS U-87MG完全培养基，# CBP60299M |
| Cryopreservation medium: | 90%FBS+10%DMSO |
| Tumor Formation: | Yes, in nude mice inoculated subcutaneously with 10(7) cells |
| Comments: | Mycoplasma contamination was eliminated in September 1975. The ATCC® HTB-14™ cell line was deposited at ATCC in 1982. STR profiling, Y-chromosome paint, and Q-band assay confirmed that the cell line is male in origin. Based on current literature, the cell line is likely a glioblastoma of CNS origin (Allen, 2016). For more information, please contact us (4008-750-250). |
